Lindbrook Capital »

Aeglea Biotherapeutics shares owned by Lindbrook Capital

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Lindbrook Capital from 13F filings

Historical chart of Lindbrook Capital investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Lindbrook Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Lindbrook Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $559 19 29.42